- Home
- EAF vs QTRX Comparison
EAF vs QTRX Comparison
Compare EAF & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EAF | QTRX |
|---|---|---|
| Founded | 1886 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Laboratory Analytical Instruments |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 183.6M | 160.0M |
| IPO Year | 2018 | 2017 |
Fundamental Metrics
Financial Performance| Metric | EAF | QTRX |
|---|---|---|
| Price | $6.72 | $3.48 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $11.75 | $6.00 |
| AVG Volume (30 Days) | 355.4K | ★ 466.3K |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $504,134,000.00 | $37,632,000.00 |
| Revenue This Year | $4.25 | $25.49 |
| Revenue Next Year | $12.49 | $10.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 64.52 |
| 52 Week Low | $0.93 | $2.40 |
| 52 Week High | $20.32 | $8.77 |
Technical Indicators
Market Signals| Indicator | EAF | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 43.55 | 40.32 |
| Support Level | $6.12 | $3.30 |
| Resistance Level | $7.85 | $3.81 |
| Average True Range (ATR) | 0.76 | 0.29 |
| MACD | 0.06 | -0.09 |
| Stochastic Oscillator | 21.00 | 2.31 |
Price Performance
Historical ComparisonAbout EAF GrafTech International Ltd.
GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals. The company has only reportable segment, Industrial Materials, is comprised of its two product categories: graphite electrodes and petroleum needle coke products used as raw material in the production of graphite electrodes.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.